Tag Archives: Steph Sherer

FOIA Inaccurately Labelled Rohrabacher-Blumenauer Senate Committee Medical Society and Ethan Russo

ASA Files Freedom of Information Act Requests

ASA Files Freedom of Information Act Requests

WASHINGTON, Nov. 9, 2017 /Weed Wire/ — On November 9, Americans for Safe Access, filed two requests under the Freedom of Information Act (FOIA) for information on any discussions the Commission had about medical cannabis and specifically the only cannabis study referenced in the President’s Commission on Combating Drug Addiction and the Opioid Crisis draft final report.

FOIA Inaccurately Labelled Rohrabacher-Blumenauer Senate Committee Medical Society and Ethan Russo

House Committee Blocks Vote to Protect Medical Cannabis Patients

WASHINGTON, Sept. 7, 2017 /Weed Wire/ – Last night, the House Committee on Rules voted to not allow a floor vote on an amendment which would continue to prevent the Department of Justice from using funds to interfere with state medical marijuana programs. The amendment, introduced by Representatives Dana Rohrabacher (R-CA) and Earl Blumenauer (D-OR) has been part of the appropriations package since 2015.

Americans for Safe Access Opioid Veterans Senate Committee

Medical Cannabis Advocates Call on Trump Administration to Use all Tools Available to Fight Opiate Crisis

WASHINGTON, June 16, 2017 /Weed Wire/ — Today, June 16th, Governor Chris Christie (NJ) will chair the first meeting of the President’s commision on Drug Addiction and Combating Opioid abuse. Americans for Safe Access has submitted comments to the Commission detailing how medical cannabis can be used as a tool in fighting the opioid epidemic.

Americans for Safe Access Opioid Veterans Senate Committee

Safe Access Tennessee Launches Grassroots Patient Membership Groups

NASHVILLE, Tenn., June 1, 2017 /Weed Wire/ — Americans for Safe Access (ASA), the nation’s largest patient-focused medical cannabis advocacy organization, is pleased to announce new membership opportunities for medical cannabis patient advocates in Tennessee.

Americans for Safe Access Opioid Veterans Senate Committee

DEA Removes Marijuana Misinformation from Website After Months of Public, Legal Pressure

WASHINGTON, Feb. 13, 2017 /Weed Wire/ — After months of public pressure, the Drug Enforcement Administration (DEA) has removed factually inaccurate information from its website.

Americans for Safe Access Opioid Veterans Senate Committee

Medical Marijuana Policy Roadmap Released by Americans for Safe Access

WASHINGTON, Dec. 8, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) released a briefing book —“Medical Cannabis in America”— calling on Congress and the Obama Administration to end the conflict between federal and state governments on medical cannabis programs.

ASA

ASA Files Petition with DOJ Demanding DEA Correct Misinformation About Cannabis

WASHINGTON, Dec. 5, 2016 /Weed Wire/ — Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research, filed a petition with the Department of Justice (DOJ) today demanding that the Drug Enforcement Administration (DEA) immediately update misinformation about cannabis.

Americans for Safe Access Opioid Veterans Senate Committee

Patient Advocacy Group Releases Comparative Analysis of DEA Marijuana Scheduling Decision

WASHINGTON, Sept. 1, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) disseminated a report comparing the body of research the Drug Enforcement Administration (DEA) used as a basis for their decision to keep cannabis (marijuana) as a Schedule I substance.

Americans for Safe Access Opioid Veterans Senate Committee

Medical Cannabis A Viable Strategy to Address the Opioid Crisis

WASHINGTON, Aug. 9, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) released the Medical Cannabis Access for Pain Treatment: A Viable Strategy to Address the Opioid Crisis report to educate legislators and health practitioners on the benefits of medical cannabis as a treatment option for the millions of patients suffering from chronic pain.

Americans for Safe Access Opioid Veterans Senate Committee

ASA: National Medical Cannabis Advocacy Group Partners with Leading Global Law Firm

NEW YORK, April 28, 2016 /Weed Wire/ — Orrick, a leading global law firm, is partnering with Americans for Safe Access’ (ASA) Patients’ Rights Project to provide pro bono support to medical cannabis patients, many if not most of whom are low-income, to navigate the often confusing legal landscape of medical cannabis laws.

Americans for Safe Access Opioid Veterans Senate Committee

Maryland Passes Bill to Expand Certifying Providers for Medical Marijuana

ANNAPOLIS, Md., April 12, 2016 /Weed Wire/ — Yesterday, the Maryland Senate by a vote of 36-10 passed HB104, Medical Cannabis – Written Certifications – Certifying Providers on the last day of the legislative session.

Americans for Safe Access Opioid Veterans Senate Committee

Patient Advocates Bring Medical Cannabis Issues to United Nations

NEW YORK, Feb. 10, 2016 /Weed Wire/ — Today Executive Director of Americans for Safe Access (ASA), Steph Sherer, and Michael Krawitz, Executive Director, Veterans For Medical Cannabis Access will join organizations and patient advocates from across the globe at at the UN Headquarters to continue preparations for the United Nations General Assembly Special Session (UNGASS 2016) on drug policy to be held April 19th-21st.

Cannabis Chemistry Subdivision

Cannabis Chemistry Subdivision to Bolster the Science of Cannabis

On. Oct. 8, 2015, the American Chemical Society’s division of Chemical Health and Safety voted to form the Cannabis Chemistry Subdivision, also known as CANN. The subdivision’s membership will include cannabis specialists in chemistry, research and industry regulations.

Guidelines

AHPA Unveils Medical Marijuana Guidelines

A common complaint made by opponents of medical marijuana is that the industry lacks standardization. They say dosage is imprecise, quality varies from plant to plant, safety regulations are insufficient and measurements are ineffective.


Top